Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
The impact of malaria-protective red blood cell polymorphisms on parasite biomass in children with severe Plasmodium falciparum malaria.
Uyoga S. et al, (2022), Nature communications, 13
Recognising the deterioration of patients in acute care wards: a qualitative study
Beane A. et al, (2022), Wellcome Open Research, 7, 137 - 137
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
Adam I. et al, (2022), Wellcome Open Research, 7, 136 - 136
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response.
Zhu L. et al, (2022), Communications biology, 5
Targeted Amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial
Wamae K. et al, (2022), Wellcome Open Research, 7, 95 - 95
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
MalariaGEN None. et al, (2022), Wellcome open research, 7
Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
McLean ARD. et al, (2021), The Lancet Infectious Diseases, 21, 1579 - 1589
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Hamaluba M. et al, (2021), The Lancet. Infectious diseases, 21, 1395 - 1406
Performance evaluation of a multinational data platform for critical care in Asia
Pisani L. et al, (2021), Wellcome Open Research, 6, 251 - 251
Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing Severity in Kilifi, Kenya.
Uyoga S. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73, e2415 - e2423
Market Formation in a Global Health Transition
de Haan F. et al, (2021), Environmental Innovation and Societal Transitions, 40, 40 - 59
Ultrasound versus Computed Tomography Assessment of Focal Lung Aeration in Invasively Ventilated ICU Patients.
Smit MR. et al, (2021), Ultrasound in medicine & biology, 47, 2589 - 2597
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
Ndwiga L. et al, (2021), International Journal for Parasitology: Drugs and Drug Resistance, 16, 155 - 161
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision
Watson JA. et al, (2021), eLife, 10
Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.
Mzumara G. et al, (2021), Malaria journal, 20
Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
Alfarsi A. et al, (2021), Scientific reports, 11